AlzeCure Pharma AB (publ) (STO:ALZCUR)
Sweden · Delayed Price · Currency is SEK 6.34
-0.02 (-0.31%)
Jul 24, 2026, 4:30 PM CET
AlzeCure Pharma AB Market Cap
AlzeCure Pharma AB has a market cap or net worth of 877.03 million as of July 24, 2026. Its market cap has increased by 224.60% in one year.
Market Cap
877.03M
Enterprise Value
846.35M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
6.34
ChartMarket Cap Chart
Since November 28, 2018, AlzeCure Pharma AB's market cap has increased from 415.42M to 877.03M, an increase of 111.12%. That is a compound annual growth rate of 10.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 877.03M | 281.60% |
| Dec 30, 2025 | 229.83M | 126.34% |
| Dec 30, 2024 | 101.54M | -47.41% |
| Dec 29, 2023 | 193.09M | -24.88% |
| Dec 30, 2022 | 257.04M | 14.39% |
| Dec 30, 2021 | 224.71M | -34.33% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Flerie AB | 1.79B |
| BioInvent International AB | 1.46B |
| Genovis AB (publ.) | 1.26B |
| Medivir AB | 1.05B |
| SynAct Pharma AB | 984.46M |
| Infant Bacterial Therapeutics AB | 883.73M |
| Xspray Pharma AB | 738.75M |
| Oncopeptides AB | 627.72M |